- Home
- SFBS vs ADMA Comparison
SFBS vs ADMA Comparison
Compare SFBS & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBS
- ADMA
- Stock Information
- Founded
- SFBS 2005
- ADMA 2004
- Country
- SFBS United States
- ADMA United States
- Employees
- SFBS N/A
- ADMA N/A
- Industry
- SFBS Major Banks
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SFBS Finance
- ADMA Health Care
- Exchange
- SFBS Nasdaq
- ADMA Nasdaq
- Market Cap
- SFBS 4.5B
- ADMA 4.1B
- IPO Year
- SFBS 2014
- ADMA N/A
- Fundamental
- Price
- SFBS $69.72
- ADMA $21.31
- Analyst Decision
- SFBS Hold
- ADMA Strong Buy
- Analyst Count
- SFBS 1
- ADMA 4
- Target Price
- SFBS $96.00
- ADMA $22.50
- AVG Volume (30 Days)
- SFBS 279.5K
- ADMA 3.7M
- Earning Date
- SFBS 04-21-2025
- ADMA 05-08-2025
- Dividend Yield
- SFBS 1.92%
- ADMA N/A
- EPS Growth
- SFBS 9.76
- ADMA N/A
- EPS
- SFBS 4.16
- ADMA 0.81
- Revenue
- SFBS $458,732,000.00
- ADMA $426,454,000.00
- Revenue This Year
- SFBS $27.73
- ADMA $18.45
- Revenue Next Year
- SFBS $15.40
- ADMA $26.96
- P/E Ratio
- SFBS $16.81
- ADMA $26.31
- Revenue Growth
- SFBS 11.73
- ADMA 65.16
- 52 Week Low
- SFBS $58.11
- ADMA $6.01
- 52 Week High
- SFBS $101.37
- ADMA $23.64
- Technical
- Relative Strength Index (RSI)
- SFBS 33.68
- ADMA 60.16
- Support Level
- SFBS $68.54
- ADMA $17.30
- Resistance Level
- SFBS $70.39
- ADMA $22.25
- Average True Range (ATR)
- SFBS 3.66
- ADMA 1.50
- MACD
- SFBS -0.35
- ADMA 0.16
- Stochastic Oscillator
- SFBS 18.28
- ADMA 83.62
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.